Musolino Antonino; Campone Mario; Neven Patrick; Denduluri Neelima; Barrios Carlos H; Cortes Javier; Blackwell Kimberly; Soliman Hatem; Kahán Zsuzsanna; Bonnefoi Herve; Squires Matthew; Zhang Yong; Deudon Stephanie; Shi Michael M; Andre Fabrice:
Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2(-) breast cancer that had progressed during or after prior endocrine therapy.
BREAST CANCER RESEARCH, 19.
ISSN 1465-5411
(2017)